Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 2
2007 1
2010 1
2011 2
2012 1
2013 11
2014 8
2015 12
2016 13
2017 12
2018 13
2019 18
2020 21
2021 47
2022 16
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 34732448

142 results
Results by year
Filters applied: . Clear all
Page 1
First-line immune-checkpoint inhibitor combination therapy for chemotherapy-eligible patients with metastatic urothelial carcinoma: A systematic review and meta-analysis.
Mori K, Pradere B, Moschini M, Mostafaei H, Laukhtina E, Schuettfort VM, Sari Motlagh R, Soria F, Teoh JYC, Egawa S, Powles T, Shariat SF; European Association of Urology–Young Academic Urologists Urothelial Carcinoma Working Group (EAU-YAU). Mori K, et al. Eur J Cancer. 2021 Jul;151:35-48. doi: 10.1016/j.ejca.2021.03.049. Epub 2021 May 4. Eur J Cancer. 2021. PMID: 33962359 Free article.
Low Geriatric Nutritional Risk Index as a Poor Prognostic Marker for Second-Line Pembrolizumab Treatment in Patients with Metastatic Urothelial Carcinoma: A Retrospective Multicenter Analysis.
Etani T, Naiki T, Sugiyama Y, Nagai T, Iida K, Noda Y, Shimizu N, Tasaki Y, Mimura Y, Okada T, Banno R, Kubota H, Hamamoto S, Ando R, Kawai N, Yasui T. Etani T, et al. Oncology. 2020;98(12):876-883. doi: 10.1159/000508923. Epub 2020 Aug 28. Oncology. 2020. PMID: 32862183
142 results